Benzinga | Jul 22, 2021 08:28AM EDT

Twist Bioscience SAYS Now Shipping Synthetic RNA Positive Controls For Delta SARS-CoV-2 Variant For Development Of Accurate Diagnostic Tests

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants first identified in India and spreading rapidly worldwide.